Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Matte

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Journal of Inherited Metabolic Disease|January 26, 2026
Molecular Profile of Mucopolysaccharidosis Type I Patients in BrazilCarlos Robson Costa Cruz, Edina Poletto, Larissa Mota Silva, et al.
Pharmaceutical Research|September 12, 2014
Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type IFabiana Quoos Mayer, Márcia Duarte Adorne, Eduardo André Bender, et al.
Renal Failure|October 18, 2008
Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical reportDaiana Benck Porsch, Ane Cláudia Fernandes Nunes, Vagner Milani, et al.
Expert Opinion on Emerging Drugs|January 12, 2016
Emerging drugs for the treatment of mucopolysaccharidosesRoberto Giugliani, Andressa Federhen, Filippo Vairo, et al.
Pharmaceutics|March 28, 2026
Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type IHallana Souza Santos, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Pharmaceutical Research|September 28, 2018
Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene TherapyRoselena Silvestri Schuh, Juliana Bidone, Edina Poletto, et al.
Plos One|April 23, 2014
An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophyNidiane C Martinelli, Carolina R Cohen, Kátia G Santos, et al.
American Journal of Medical Genetics. Part A|June 14, 2006
Further cases of "neighbor" mutations in mucopolysaccharidosis type IIIda V D Schwartz, Luciane C Lima, Karen Tylee, et al.
Orphanet Journal of Rare Diseases|January 14, 2014
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristicsClarissa Troller Habekost, Pedro Schestatsky, Vitor Felix Torres, et al.
Metabolic Brain Disease|April 30, 2015
Progression rate of myelopathy in X-linked adrenoleukodystrophy heterozygotesClarissa Troller Habekost, Fernanda Santos Pereira, Carmen Regla Vargas, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Journal of Inherited Metabolic Disease|January 26, 2026
Molecular Profile of Mucopolysaccharidosis Type I Patients in BrazilCarlos Robson Costa Cruz, Edina Poletto, Larissa Mota Silva, et al.
Pharmaceutical Research|September 12, 2014
Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type IFabiana Quoos Mayer, Márcia Duarte Adorne, Eduardo André Bender, et al.
Renal Failure|October 18, 2008
Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical reportDaiana Benck Porsch, Ane Cláudia Fernandes Nunes, Vagner Milani, et al.
Expert Opinion on Emerging Drugs|January 12, 2016
Emerging drugs for the treatment of mucopolysaccharidosesRoberto Giugliani, Andressa Federhen, Filippo Vairo, et al.
Pharmaceutics|March 28, 2026
Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type IHallana Souza Santos, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Pharmaceutical Research|September 28, 2018
Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene TherapyRoselena Silvestri Schuh, Juliana Bidone, Edina Poletto, et al.
Plos One|April 23, 2014
An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophyNidiane C Martinelli, Carolina R Cohen, Kátia G Santos, et al.
American Journal of Medical Genetics. Part A|June 14, 2006
Further cases of "neighbor" mutations in mucopolysaccharidosis type IIIda V D Schwartz, Luciane C Lima, Karen Tylee, et al.
Orphanet Journal of Rare Diseases|January 14, 2014
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristicsClarissa Troller Habekost, Pedro Schestatsky, Vitor Felix Torres, et al.
Metabolic Brain Disease|April 30, 2015
Progression rate of myelopathy in X-linked adrenoleukodystrophy heterozygotesClarissa Troller Habekost, Fernanda Santos Pereira, Carmen Regla Vargas, et al.
Pageof 16